The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported the following relevant financial relationship(s) during the content development process for this activity:
Richard J. Auchus, MD, PhD, has served as a consultant to Adrenas Therapeutics, Corcept Therapeutics, Janssen Pharmaceuticals, Novartis Pharmaceuticals, Quest Diagnostics, Selenity Therapeutics, and Strongbridge Biopharma; and has conducted research for Neurocrine Biosciences, Novartis Pharmaceuticals, Spruce Biosciences, and Strongbridge Biopharma.
Carolyn B. Becker, MD, receives royalties from UpToDate as a chapter author.
Andrea D. Coviello, MD, has served as a consultant and speaker to Novo Nordisk; and has received research support from Allergan, Bristol-Myers Squibb, and Regeneron.
Serge A. Jabbour, MD, has served as a consultant to AstraZeneca, Eli Lilly, and Janssen.
Laurence Katznelson, MD, has received research support from Chiasma and Novartis; and has served as an advisory board member to Chiasma and Pfizer.
Michelle F. Magee, MD, has had her institution receive research support from Lilly, Mytonomy, and Sanofi; has served as a speaker for PRIMED; and has served as a speaker and consultant to Mytonomy.
Kathryn A. Martin, MD, serves as an editor for UpToDate.
The following faculty reported no relevant financial relationships: Frances J. Hayes, MB BCh, BAO, and Elizabeth N. Pearce, MD, MSc.
The medical editor for this activity reported no relevant financial relationships: Abbie L. Young, MS, CGC, ELS(D).
Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.